TREATMENT EFFICACY AND OUTCOMES OF RARE HIV-RELATED PLASMABLASTIC LYMPHOMA: THE RESULTS OF MULTICENTER RETROSPECTIVE STUDY IN RUSSIA

EHA Library, Marina Popova, 325316

ANALYSIS OF PROGNOSTIC FACTORS IN PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA TREATED BY DA-EPOCH-R AND R-CHOP

EHA Library, Yana Stepanishyna, 325317

VALUE OF MICROSATELLITE INSTABILITY MARKERS IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA DIAGNOSTICS

EHA Library, Natalya Risinskaya, 325318

DIAGNOSTIC YIELD AND SAFETY OF IMAGE-GUIDED PERCUTANEOUS SPLENIC BIOPSY – A TWO-CENTRE EXPERIENCE FROM THE EAST OF ENGLAND

EHA Library, Francis Anyanwu, 325319

IDENTIFYING THE INTRAVASCULAR LARGE B-CELL LYMPHOMA BY FDG PET/CT IMAGING: A SINGLE-CENTER, MATCHED CASE-CONTROL STUDY

EHA Library, Shenmiao Yang, 325320

GLOMERULAR FILTRATION RATE (GFR) IS AN INDEPENDENT PROGNOSTIC FACTOR AFFECTING SURVIVAL OF PATIENTS WITH B-LARGE CELL LYMPHOMAS (B-LCL)

EHA Library, Igor Aurer, 325321

A NOVEL LIPID-COVERED PROGNOSTIC SCORING MODEL FOR NEWLY DIAGNOSED MATURE T AND NK CELL LYMPHOMAS

EHA Library, Tiange Lu, 325322

UTILITY OF PROGNOSTIC INDICES IN DIFFUSE LARGE B-CELL LYMPHOMA FOR THE DETECTION OF HIGH RISK PATIENTS.

EHA Library, Patricia López-Menargues, 325323

MODIFIED R-BFM IMMUNOCHEMOTHERPY RESULTS HIGHER FREQUENCY OF COMPLETE REMISSION THAN R-DA-EPOCH/R-CHOP IN PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMA DOUBLE-HIT TRANSFORMED FROM FOLLICULAR LYMPHOMA.

EHA Library, Anna Misyurina, 325324

DEVELOPMENT AND VALIDATION OF A PROGNOSTIC NOMOGRAM FOR PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA

EHA Library, Hua Wang, 325325

EFFICACY AND SAFETY OF EFGARTIGIMOD PH20 SUBCUTANEOUS IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: ADVANCE SC, A GLOBAL PHASE 3 CLINICAL TRIAL IN PROGRESS

EHA Library, Vickie McDonald, 325326

PERI-OPERATIVE PK-GUIDED DOSING OF DESMOPRESSIN COMBINED WITH FVIII CONCENTRATES IN HEMOPHILIA A: FINAL RESULTS OF THE DAVID STUDY

EHA Library, Lorenzo Romano, 325327

APPLICATION OF THROMBOELASTOGRAPHIC MARKERS TO PREDICT THE SURVIVAL IN ACUTE TRAUMA PATIENTS.

EHA Library, Hyunjung Kim, 325328

POPULATION PHARMACOKINETIC MODELING OF FACTOR CONCENTRATES IN HEMOPHILIA: A DETAILED OVERVIEW FOR CLINICIANS AND EVALUATION OF OUR BEST PRACTICE.

EHA Library, Tine Goedhart, 325329

FACTOR XI DEFICIENCY IN PREGNANT WOMEN: A GENOTYPE TO PHENOTYPE CORRELATION AND ANALYSIS

EHA Library, Guilherme Sacchi de Camargo Correia, 325330

ACQUIRED VON WILLEBRAND DISEASE: THE DIAGNOSIS AND MANAGEMENT OF AN UNDERDIAGNOSED COAGULOPATHY

EHA Library, antonietta ferretti, 325331

INVESTIGATION OF PRETERM INTRAVENTRICULAR HEMORRHAGE-INDUCED INFLAMMATORY RESPONSE AND MICRORNA LEVELS IN HUMAN CHOROID PLEXUS EPITHELIAL CELLS

EHA Library, Zsolt Fejes, 325332

THE ANALYSIS OF THE TREATMENT OUTCOME OF PATIENTS WITH ACQUIRED HEMOPHILIA IN CROATIA

EHA Library, Marijo Vodanovic, 325333

HAEMOPHILIA B LEYDEN, AN AGE-RELATED MECHANISM FOR AN INCREASE OF FACTOR IX: CASE REPORT AND LITERATURE REVIEW

EHA Library, Cristina Alburquerque-Prieto, 325334

HEMOPHILIA A SELF-MANAGEMENT – PATIENTS’ PERSPECTIVES AND CHALLENGES

EHA Library, Irena Preložnik Zupan, 325335

CONGENITAL COMBINED VITAMIN K-DEPENDENT CLOTTING FACTORS DEFICIENCY, CASE REPORTS

EHA Library, Dmitry Florinskiy, 325336

IS ANTI-NUCLEAR ANTIBODY POSITIVITY A FACTOR FOR AFFECTING TREATMENT RESPONSE IN IMMUNE THROMBOCYTOPENIA PATIENTS ON ELTROMBOPAG?

EHA Library, Mehmet Baysal, 325337

NEW LIKELY PATHOGENIC VARIANTS IN THREE SPANISH PATIENTS WITH MILD HEMOPHILIA A AND B: GENETIC COUNSELING.

EHA Library, Maria Civeira, 325338

BEVACIZUMAB AND RESCUE TREATMENT FOR SEVERE GASTROINTESTINAL BLEEDING IN VON WILLEBRAND DISEASE

EHA Library, D. Rochate, 325339

ANTI-COX-2 AUTOANTIBODY AS A NOVEL DIAGNOSTIC MARKER IN APLASTIC ANEMIA

EHA Library, Tiina Kelkka, 325340

COMPARISON OF LYMPHOCYTE SUBSETS IN HYPOPLASTIC MYELODYSPLASTIC SYNDROMES AND APLASTIC ANEMIA

EHA Library, Meili Ge, 325341

DRIED BLOOD SPOT METABOLOMICS REVEALS A METABOLIC FINGERPRINT WITH DIAGNOSTIC POTENTIAL FOR DIAMOND BLACKFAN ANEMIA

EHA Library, Birgit Van Dooijeweert, 325342

A PIGA CONDITIONAL KNOCK-OUT MOUSE MODEL MEDIATED BY VAV-ICRE: STABLE GLYCOSYLPHOSPHATIDYLINOSITOL-DEFICIENT AND MILD HEMOLYSIS

EHA Library, Yingying Chen, 325343

CYTOKINE-PRODUCING ABILITY OF MESENCHYMAL CELLS OF THE BONE MARROW STROMA IN CASE OF NEUTROPENIA IN CHILDREN

EHA Library, Konstantin Vetoshkin, 325344

BCX9930, A NOVEL ORAL FACTOR D INHIBITOR, HAS POSITIVE EFFECTS ON HEMOLYSIS AND CLINICAL OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) NAÏVE TO COMPLEMENT INHIBITORS

EHA Library, Andrew McDonald, 325345

RAVULIZUMAB ADMINISTERED SUBCUTANEOUSLY VERSUS INTRAVENOUSLY IN ADULT PATIENTS WITH PNH PREVIOUSLY TREATED WITH ECULIZUMAB: RESULTS FROM A PHASE 3 RANDOMIZED, OPEN-LABEL STUDY

EHA Library, Mustafa N. Yenerel, 325346

LONG-TERM FOLLOW UP AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT FOR IDIOPATHIC SEVERE APLASTIC ANEMIA. THE EXPERIENCE OF THE SPANISH GROUP OF HEMATOPOIETIC STEM CELL TRANSPLANT (GETH).

EHA Library, Lucrecia Yañez, 325347

LONGITUDINAL CLINICAL AND LABORATORY DATA AND OUTCOME OF PATIENTS WITH CHRONIC IDIOPATHIC NEUTROPENIA

EHA Library, Stavros Papadakis, 325348

BCX9930, AN ORAL FACTOR D INHIBITOR, CONTROLS EXTRAVASCULAR HEMOLYSIS AND ALLEVIATES ASSOCIATED SYMPTOMS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA INADEQUATELY CONTROLLED ON C5 INHIBITORS

EHA Library, Austin Kulasekararaj, 325349

PHARMACOKINETICS, PHARMACODYNAMICS, EFFICACY AND SAFETY OF RAVULIZUMAB IN CHILDREN AND ADOLESCENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: INTERIM ANALYSIS OF A PHASE 3, OPEN-LABEL STUDY

EHA Library, Satheesh Chonat, 325350

REAL - WORLD SCENARIO OF RESPONSE WITH LONG - TERM USE OF ANDROGENIC STEROIDS IN PATIENTS WITH ACQUIRED APLASTIC ANEMIA: REPORT FROM A TERTIARY CARE HOSPITAL IN WEST BENGAL, INDIA

EHA Library, Ankita Sen, 325351

MANAGEMENT OF MENINGOCOCCAL DISEASE RISK IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON COMPLEMENT INHIBITORS: 18 YEARS’ EXPERIENCE FROM THE UK NATIONAL PNH SERVICE IN LEEDS

EHA Library, Louise Arnold, 325352

ELTROMBOPAG PLUS IMMUNOSUPPRESSIVE THERAPY VERSUS MATCHED SIBLING DONOR TRANSPLANTATION AS FIRST-LINE THERAPY FOR SEVERE APLASTIC ANEMIA – A META-ANALYSIS

EHA Library, Jiang Ji, 325353

SAFETY OF RAVULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: STUDY 301/302 2-YEAR RESULTS

EHA Library, Régis Peffault de Latour, 325354

EFFECT OF PEGCETACOPLAN ON QUALITY OF LIFE IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: WEEK 48 OF PEGASUS PHASE 3 TRIAL COMPARING PEGCETACOPLAN TO ECULIZUMAB

EHA Library, Alexander Röth, 325355

RISK OF SERIOUS INFECTIONS IN PATIENTS WITH OR WITHOUT PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A REAL-WORLD MATCHED COHORT ANALYSIS

EHA Library, Richard Ofori-Asenso, 325356

REAL WORLD DATA OF PATIENTS WITH ACQUIRED PURE RED CELL APLASIA: A SINGLE INSTITUTION EXPERIENCE

EHA Library, Moon Ley Tung, 325357

CLINICAL CHARACTERISTICS OF 512 ECULIZUMAB-NAIVE PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS IN CHINA: A SINGLE-CENTER OBSERVATIONAL STUDY

EHA Library, Yali Du, 325358

IMPACT OF UNFAVORABLE GENETICS ON MINIMAL RESIDUAL DISEASE (MRD) RESPONSE TO VENETOCLAX+RITUXIMAB RETREATMENT IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL): PHASE 3 MURANO SUBSTUDY

EHA Library, Jenny Qun Wu, 325359

TPL2 ABLATION ACCELERATES DISEASE DEVELOPMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA EU-TCL1 MOUSE MODEL

EHA Library, Jessica Bordini, 325360

LONG NON‐CODING RNA LINC00525 PROMOTES PROLIFERATION AND INHIBITS APOPTOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA CELLS BY TARGETING MIR‐338‐3P/WWP1 AXIS

EHA Library, Lei Fan, 325361

COMPARING MACHINE LEARNING-BASED PREDICTION OF TREATMENT IN CLL USING RECURRENT GENE MUTATIONS VERSUS (PARA)CLINICAL FEATURES

EHA Library, Mehdi Parviz, 325362

MULTIREGIONAL SEQUENCING AND CIRCULATING TUMOR DNA ANALYSIS PROVIDE COMPLEMENTARY APPROACHES FOR COMPREHENSIVE DISEASE PROFILING OF SMALL LYMPHOCYTIC LYMPHOMA

EHA Library, Riccardo Moia, 325363

CFOS/MIR-181A CIRCUITRY IS INVOLVED IN BCR SIGNALLING AND DEATH OF CLL CELLS.

EHA Library, Alice Ramassone, 325364

NUSAP1 ENHANCES DRUG RESISTANCE BY BINDING TO RAD51 THROUGH DNA DAMAGE REPAIR PATHWAY IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Yang Han, 325365

CLINICAL VALIDATION OF A NGS CAPTURE PANEL TO IDENTIFY MUTATIONS, COPY NUMBER ALTERATIONS AND CHROMOSOMAL REARRANGEMENTS IN MATURE B-CELL NEOPLASMS

EHA Library, Andrea Gomez Llonin, 325366

INFLUENCE OF THE STATE OF THE 'TELOMERE-TELOMERASE' SYSTEM ON THE COURSE OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Isaeva Natalia, 325367

BCMA AS A TARGET FOR T-CELL REDIRECTING BISPECIFIC ANTIBODIES IN B-CELL LYMPHOMAS AND CLL

EHA Library, Anne Martens, 325368

IN SILICO PREDICTION REVEALS PUTATIVE T-CELL CLASS I NEOEPITOPES WITHIN THE CLONOTYPIC BCR IG OF CLL PATIENTS

EHA Library, Anna Vardi, 325369

SWATH-MS PROTEOMICS AS A NEW TOOL FOR DISCOVERING POTENTIAL DRUG TARGETS AND BIOMARKERS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Umair T Khan, 325370

CHARACTERIZATION OF STAT5B MUTATIONS AND TCRΒ REPERTOIRE IN CD4+ T LARGE GRANULAR LYMPHOCYTE LEUKEMIA

EHA Library, Antonella Teramo, 325371

AUTOPHAGY-RELATED GENETIC VARIANTS INFLUENCE THE RISK OF DEVELOPING CHRONIC LYMPHOCYTIC LEUKEMIA: A STUDY IN THE CONTEXT OF THE CRUCIAL CONSORTIUM

EHA Library, Ana Moñiz Díez, 325372

THE GUT MICROBIOME IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Tereza Faitova, 325373

EX VIVO DRUG SENSITIVITY IDENTIFIES COMBINATION TREATMENT WITH PI3K/BCL-2 INHIBITORS FOR MONOTHERAPY-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Sigrid Skånland, 325374

THE IGLV3-21 LIGHT CHAIN ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Nadiia Bilous, 325375

ANALYSIS OF GENOMIC COMPLEXITY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) USING OPTICAL GENOME MAPPING

EHA Library, Anna Puiggros, 325376

THE IDO-KYN-AHR PATHWAY PROMOTES CHRONIC LYMPHOCYTIC LEUKEMIA CELLS SURVIVAL AND MITIGATES THE APOPTOTIC EFFECT OF ABT-199

EHA Library, Claudio Giacinto Atene, 325377

LNCRNA LANDSCAPE ANALYSIS IDENTIFIED LNCRNA LEF-AS1 AS AN ONCOGENE THAT UPREGULATES LEF1 AND PROMOTES SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Lei Fan, 325378

DISCOVERY OF HBW-3-10: A POTENT, ORALLY ACTIVE, REVERSIBLE BRUTON’S TYROSINE KINASE (BTK) INHIBITOR WITH ANTITUMOR ACTIVITIES IN MICE

EHA Library, Chester Yuan, 325379

TARGETING CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) CELLS WITH THE GLYCOGEN SYNTHASE KINASE-3 BETA (GSK-3Β)-SELECTIVE SMALL MOLECULE INHIBITOR, 9-ING-41

EHA Library, Estevao Carlos Silva Barcelos, 325380

INFLUENCE OF POLYMORPHISMS OF CODON 72 OF TP53 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Martin-Antonio Cabero-Becerra, 325381

CRISPR/CAS9 AND MRNA-BASED GENE EDITING AND EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS

EHA Library, Anna Kabanova, 325382

THE SIGNS OF NEGATIVE SELECTION IN IGHV FRAMEWORK REGIONS ARE ASSOCIATED WITH WORSE OVERALL SURVIVAL OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Iryna Abramenko, 325383

GENE EXPRESSION MODEL TO IDENTIFY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS WITH AN ULTRA-STABLE DISEASE. A CAMPUS CLL STUDY.

EHA Library, Ilaria Del Giudice, 325384

SOMATIC HYPERMUTATION PROFILES IN STEREOTYPED IGHV4-34 RECEPTORS FROM SOUTH AMERICAN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Carmen Stanganelli, 325385

NGS APPROACH FOR IGHV REARRANGEMENT ANALYSIS IN CLL PATIENTS WITH OLIGOCLONAL DISEASE

EHA Library, Bella Biderman, 325386

SYSTEMATIC TRANSCRIPTOME ANALYSIS REVEALS DISTINCT COMPETING ENDOGENOUS RNA NETWORK IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Ya Zhang, 325387

CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): HIGH-RISK DATA FROM AN IRISH POPULATION.

EHA Library, Carmel Waldron, 325388

INFLUENCE OF INFLAMMATORY CYTOKINES ON S100A PROTEINS EXPRESSION IN CLL PATIENTS

EHA Library, Olivera Mitrovic, 325389

RELEVANCE OF NRF2/KEAP1 AXIS IN CHRONIC LYMPHOCYTIC LEUKEMIA DEVELOPMENT

EHA Library, Ana Bela Sarmento-Ribeiro, 325390

OTHER MALIGNANCIES IN THE HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA – A RETROSPECTIVE, MULTICENTER COHORT STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL, IN HARMONY

EHA Library, Thomas Chatzikonstantinou, 325391

VENETOCLAX-OBINUTUZUMAB MODULATES CLONAL GROWTH: RESULTS OF A POPULATION-BASED MINIMAL RESIDUAL DISEASE MODEL FROM THE RANDOMIZED CLL14 STUDY

EHA Library, Othman Al-Sawaf, 325392

PIRTOBRUTINIB (LOXO-305), A NEXT GENERATION, HIGHLY SELECTIVE, NON-COVALENT BTK INHIBITOR IN PREVIOUSLY TREATED CLL/SLL: RESULTS FROM THE PHASE 1/2 BRUIN STUDY

EHA Library, Lindsey Roeker, 325393

MINIMAL RESIDUAL DISEASE-DRIVEN TREATMENT INTENSIFICATION WITH SEQUENTIAL ADDITION OF IBRUTINIB (IBR) TO VENETOCLAX (VEN) IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): THE IMPROVE STUDY

EHA Library, Lydia Scarfò, 325394

REAL-WORLD APPLICATION OF NATIONAL COMPREHENSIVE CANCER NETWORK CLINICAL PRACTICE GUIDELINES IN ONCOLOGY (NCCN GUIDELINES®) FOR CLL/SLL FROM THE INFORMCLL REGISTRY

EHA Library, Jacqueline Barrientos, 325395

IBRUTINIB TREATMENT IN THE FIRST-LINE SETTING FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: UP TO 7 YEARS OF FOLLOW-UP IN THE RESONATE-2 STUDY

EHA Library, Paolo Ghia, 325396

SECOND PRIMARY MALIGNANCIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A NATIONWIDE, POPULATION-BASED STUDY IN THE NETHERLANDS

EHA Library, Lina Van Der Straten, 325397

TG-1701, A SELECTIVE BRUTON TYROSINE KINASE (BTK) INHIBITOR, AS MONOTHERAPY AND IN COMBINATION WITH UBLITUXIMAB AND UMBRALISIB (U2) IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND LYMPHOMA

EHA Library, Chan Y. Cheah, 325398

ZANUBRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: 34-MONTH FOLLOW-UP RESULTS

EHA Library, Wei Xu, 325399

CONDITIONAL RELATIVE SURVIVAL AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A NATIONWIDE, POPULATION-BASED STUDY IN THE NETHERLANDS

EHA Library, Lina Van Der Straten, 325400

SYSTOLIC FUNCTION OF THE LEFT VENTRICULAR MYOCARDIAL IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING IBRUTINIB.

EHA Library, Elena Emelina, 325401

PRELIMINARY RESULTS OF THE PHASE 2 STUDY OF ZANUBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED B-CELL MALIGNANCIES INTOLERANT TO IBRUTINIB AND/OR ACALABRUTINIB

EHA Library, Mazyar Shadman, 325402

A PHASE 1A/B DOSE ESCALATION STUDY OF THE MUTATION AGNOSTIC BTK/FLT3 INHIBITOR LUXEPTINIB (CG-806) IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL MALIGNANCIES

EHA Library, Rafael Bejar, 325403

TEN-YEAR FOLLOW-UP OF 415 CLL PATIENTS TREATED WITH FLUDARABINE CYCLOPHOSPHAMIDE-BASED CHEMOIMMUNOTHERAPY IN THE FRONTLINE ARCTIC AND ADMIRE TRIALS, A COMPREHENSIVE ASSESSMENT OF PROGNOSTIC FACTORS

EHA Library, David Allsup, 325404

OUTCOME OF 100 TP53-DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED FRONT-LINE WITH IBRUTINIB. A REAL-LIFE CAMPUS CLL STUDY.

EHA Library, Andrea Visentin, 325405

REAL-WORLD EFFICACY AND SAFETY OF VENETOCLAX IN CHRONIC LYMPHOCYTIC LEUKAEMIA – FIRST DATA FROM THE VERONE STUDY, IN PATIENTS WITH VENETOCLAX MONOTHERAPY

EHA Library, Loïc Ysebaert, 325406

POTENTIAL CAPABILITIES OF MRNA ROR1 AND MIR-155 FOR MRD ASSESSMENT IN CLL

EHA Library, Marina Stolyar, 325407

SAFETY AND EFFECTIVENESS OF VENETOCLAX IN COMBINATION WITH RITUXIMAB IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY CLL TREATED UNDER REAL-LIFE CONDITIONS – DATA FROM THE OBSERVATIONAL STUDY VERVE

EHA Library, Ingo Schwaner, 325408

COMPARISON OF VENETOCLAX INPATIENT AND OUTPATIENT RAMP-UP STRATEGIES FOR CLL. UK MULTICENTRE RESTROSPECTIVE STUDY

EHA Library, Rocío Figueroa Mora, 325409

MOLTO, A MULTICENTER, OPEN LABEL, UNCONTROLLED, PHASE II CLINICAL TRIAL ON SAFETY AND EFFICACY OF VENETOCLAX, ATEZOLIZUMAB AND OBINUTUZUMAB IN RICHTER TRANSFORMATION OF CLL: SAFETY INTERIM ANALYSIS

EHA Library, Anna Maria Frustaci, 325410

TREATMENT OF CLL RELAPSED/REFRACTORY PATIENTS IN COVID-19 PANDEMIC: A REAL-LIFE EXPERIENCE WITH VENETOCLAX-RITUXIMAB COMBINATION IN SOUTHERN ITALY.

EHA Library, Stefano Molica, 325411

LEUKEMIA CUTIS IN CHRONIC LYMPHOCYTIC LEUKEMIA: A RETROSPECTIVE STUDY OF THE FRENCH INNOVATIVE LEUKEMIA ORGANIZATION (FILO)

EHA Library, Gregory Lazarian, 325412

MANAGEMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND ARTERIAL HYPERTENSION WHO ARE ON IBRUTINIB THERAPY.

EHA Library, Elena Emelina, 325413

EFFECTIVENESS AND SAFETY OF IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MANTLE CELL LYMPHOMA (MCL) IN BELGIAN ROUTINE CLINICAL PRACTICE WITH A 3-YEAR FOLLOW-UP

EHA Library, Ann Janssens, 325414

NEUTROPHIL EXTRACELLULAR TRAPS ARE INCREASED IN CHRONIC MYELOID LEUKEMIA AND ARE DIFFERENTIALLY AFFECTED BY TYROSINE KINASE INHIBITORS

EHA Library, Alona Telerman, 325415